What is the address of DR MALAKZADEH,cardiologue.?

The registered office of DR MALAKZADEH,cardiologue. is located at Avenue du Castel 5, 1420 Braine-l'Alleud.

Is DR MALAKZADEH,cardiologue. still active?

Yes. According to the CBE (18 September 2026) DR MALAKZADEH,cardiologue. is active, legal situation “Normale toestand”, started on 6 November 2012.

Is DR MALAKZADEH,cardiologue. registered on Peppol?

No, DR MALAKZADEH,cardiologue. is currently not registered on the Peppol network.

What is the enterprise number of DR MALAKZADEH,cardiologue.?

The enterprise number of DR MALAKZADEH,cardiologue. is BE0500584930.

When was DR MALAKZADEH,cardiologue. founded?

DR MALAKZADEH,cardiologue. was founded on 6 November 2012.

Who are the directors of DR MALAKZADEH,cardiologue.?

According to the 2025 annual accounts, the directors of DR MALAKZADEH,cardiologue. are: Mohammad Ali Malakzadeh.

Is DR MALAKZADEH,cardiologue. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 November 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR MALAKZADEH,cardiologue. make in 2025?

DR MALAKZADEH,cardiologue. posted a profit after taxes of € 131,863 in financial year 2025.

What is the revenue of DR MALAKZADEH,cardiologue.?

As a small company, DR MALAKZADEH,cardiologue. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 193,142.

DR MALAKZADEH,cardiologue. (Private Limited)

Dossier DR MALAKZADEH,cardiologue., printed on 18 September 2026 from databakkes.be/en/0500584930/dr-malakzadeh-cardiologue. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR MALAKZADEH,cardiologue. from Braine-l'Alleud, company number BE0500584930, closed financial year 2025 with a result of € 131,863 after tax. For that financial year DR MALAKZADEH,cardiologue. recorded a gross margin of € 193,142 and equity of € 268,487. Compared with financial year 2024, the result moved from € 92,395 to € 131,863. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 268,487

▲ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 131,863

▲ 43% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 51,335

▲ € 46,745 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 69,511 paid out

53 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

€ 17,592

Loans from banks and other lenders, long and short.

Taxes and wages

€ 30,485

▼ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 144,112 Gross margin 2022: € 144,112 First fiscal year in the series	€ 147,313 Gross margin 2023: € 147,313 ▲ 2% vs 2022 (€ 144,112) Favourable step	€ 131,115 Gross margin 2024: € 131,115 ▼ 11% vs 2023 (€ 147,313) Unfavourable step	€ 193,142 Gross margin 2025: € 193,142 ▲ 47% vs 2024 (€ 131,115) Favourable step	▲ 47%
Profit after taxes	€ 106,073 Profit after taxes 2022: € 106,073 First fiscal year in the series	€ 104,044 Profit after taxes 2023: € 104,044 ▼ 2% vs 2022 (€ 106,073) Unfavourable step	€ 92,395 Profit after taxes 2024: € 92,395 ▼ 11% vs 2023 (€ 104,044) Unfavourable step	€ 131,863 Profit after taxes 2025: € 131,863 ▲ 43% vs 2024 (€ 92,395) Favourable step	▲ 43%
Equity	€ 89,934 Equity 2022: € 89,934 First fiscal year in the series	€ 113,739 Equity 2023: € 113,739 ▲ 26% vs 2022 (€ 89,934) Favourable step	€ 206,135 Equity 2024: € 206,135 ▲ 81% vs 2023 (€ 113,739) Favourable step	€ 268,487 Equity 2025: € 268,487 ▲ 30% vs 2024 (€ 206,135) Favourable step	▲ 30%
Total debts	€ 162,258 Total debts 2022: € 162,258 First fiscal year in the series	€ 155,335 Total debts 2023: € 155,335 ▼ 4% vs 2022 (€ 162,258) Favourable step	€ 49,694 Total debts 2024: € 49,694 ▼ 68% vs 2023 (€ 155,335) Favourable step	€ 48,077 Total debts 2025: € 48,077 ▼ 3% vs 2024 (€ 49,694) Favourable step	▼ 3%
Cash	€ 36,644 Cash 2022: € 36,644 First fiscal year in the series	€ 11,843 Cash 2023: € 11,843 ▼ 68% vs 2022 (€ 36,644) Unfavourable step	€ 4,590 Cash 2024: € 4,590 ▼ 61% vs 2023 (€ 11,843) Unfavourable step	€ 51,335 Cash 2025: € 51,335 ▲ € 46,745 vs 2024 (€ 4,590) Favourable step	▲ € 46,745
Retained profit	€ 77,534 Retained profit 2022: € 77,534 First fiscal year in the series	€ 112,739 Retained profit 2023: € 112,739 ▲ 45% vs 2022 (€ 77,534) Favourable step	€ 205,135 Retained profit 2024: € 205,135 ▲ 82% vs 2023 (€ 112,739) Favourable step	€ 267,487 Retained profit 2025: € 267,487 ▲ 30% vs 2024 (€ 205,135) Favourable step	▲ 30%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 68,839 Dividend 2023: € 68,839 ▼ 31% vs 2022 (€ 100,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 68,839) Unchanged	€ 69,511 Dividend 2025: € 69,511 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 40,033 Bank debt 2023: € 40,033 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 40,033) Favourable step	€ 17,592 Bank debt 2025: € 17,592 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 252,192 Balance sheet total 2022: € 252,192 First fiscal year in the series	€ 269,074 Balance sheet total 2023: € 269,074 ▲ 7% vs 2022 (€ 252,192) Unchanged	€ 255,829 Balance sheet total 2024: € 255,829 ▼ 5% vs 2023 (€ 269,074) Unchanged	€ 316,564 Balance sheet total 2025: € 316,564 ▲ 24% vs 2024 (€ 255,829) Unchanged	▲ 24%

Key figures of DR MALAKZADEH,cardiologue., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR MALAKZADEH,cardiologue.?

What happened at DR MALAKZADEH,cardiologue. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 131,863 (▲ 43% vs 2024). filed late Source: NBB ↗
2023 Mohammad Ali Malakzadeh became a director. NBB
Nov 6, 2012 Start of the company according to the CBE. KBO
Nov 5, 2012 New establishment in Braine-l'Alleud. KBO

In short

From € 106,073 profit in 2022 to € 131,863 profit in 2025.

Paid € 179,871 in corporate taxes since 2022.

Best year ever: 2025, with € 131,863 profit.

Paid out € 238,350 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR MALAKZADEH,cardiologue.? We notify you, reason included.

Follow DR MALAKZADEH,cardiologue.

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Mohammad Ali Malakzadeh

DR MALAKZADEH,cardiologue.

Cardiocenter Brussel

CARDIOCENTER SINT-MARIA HALLE

Behind DR MALAKZADEH,cardiologue. is Mohammad Ali Malakzadeh. Mohammad Ali Malakzadeh is also behind Cardiocenter Brussel and CARDIOCENTER SINT-MARIA HALLE.

See the full network in the app

Directors

According to the 2025 annual accounts

Mohammad Ali Malakzadeh

Director

Also active at: Cardiocenter Brussel, CARDIOCENTER SINT-MARIA HALLE

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue du Castel 5

1420 Braine-l'Alleud

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0500.584.930
VAT number: BE 0500.584.930
Registered office: Avenue du Castel 5, 1420 Braine-l'Alleud
Names & denominations: DR MALAKZADEH,cardiologue.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 November 2012
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗